Bristol Myers Squibb to Participate in Citi’s 2024 Global Healthcare Conference
Bristol Myers Squibb (NYSE: BMY) has announced its participation in Citi's 2024 Global Healthcare Conference. The company's board chair and CEO, Christopher Boerner, Ph.D., will engage in a fireside chat on December 3, 2024, starting at 8:00 a.m. ET. The session will be accessible to investors and the public through a live webcast at http://investor.bms.com, with an archived version available after the event.
Bristol Myers Squibb (NYSE: BMY) ha annunciato la sua partecipazione alla Conferenza Globale sulla Salute di Citi 2024. Il presidente del consiglio e CEO dell'azienda, Christopher Boerner, Ph.D., parteciperà a una chat informale il 3 dicembre 2024, che avrà inizio alle 8:00 ET. La sessione sarà accessibile agli investitori e al pubblico tramite una diretta web all'indirizzo http://investor.bms.com, con una versione archiviata disponibile dopo l'evento.
Bristol Myers Squibb (NYSE: BMY) ha anunciado su participación en la Conferencia Global de Salud de Citi 2024. El presidente de la junta y CEO de la compañía, Christopher Boerner, Ph.D., participará en una charla informal el 3 de diciembre de 2024, comenzando a las 8:00 a.m. ET. La sesión será accesible para inversores y el público a través de una transmisión en vivo en http://investor.bms.com, con una versión archivada disponible después del evento.
브리스틀-마이어스 스퀴브 (NYSE: BMY)가 씨티의 2024년 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 이사장 및 CEO인 크리스토퍼 보어너, 박사가 2024년 12월 3일에 오전 8시 ET부터 시작되는 화상 대담에 참여합니다. 이 세션은 투자자와 대중이 http://investor.bms.com을 통해 실시간 웹캐스트로 접속할 수 있으며, 행사 후에는 아카이브된 버전도 제공됩니다.
Bristol Myers Squibb (NYSE: BMY) a annoncé sa participation à la Conférence Mondiale sur la Santé de Citi 2024. Le président et CEO de la société, Christopher Boerner, Ph.D., participera à une discussion informelle le 3 décembre 2024 à 8h00 ET. La session sera accessible aux investisseurs et au public via un webinaire en direct à http://investor.bms.com, avec une version archivée disponible après l'événement.
Bristol Myers Squibb (NYSE: BMY) hat seine Teilnahme an der Citi Global Healthcare Conference 2024 bekannt gegeben. Der Vorsitzende des Unternehmens und CEO, Christopher Boerner, Ph.D., wird am 3. Dezember 2024 um 8:00 Uhr ET an einem informellen Gespräch teilnehmen. Die Sitzung wird für Investoren und die Öffentlichkeit über einen Live-Webcast unter http://investor.bms.com zugänglich sein, mit einer archivierten Version, die nach der Veranstaltung verfügbar ist.
- None.
- None.
Christopher Boerner, Ph.D., board chair and chief executive officer, will take part in a fireside chat on December 3, 2024. He will answer questions about the company beginning at 8:00 a.m. ET.
Investors and the general public are invited to listen to a live webcast of the session by visiting http://investor.bms.com. An archived edition of this session will be available following its conclusion.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20241126806842/en/
Media:
media@bms.com
Investors:
investor.relations@bms.com
Source: Bristol Myers Squibb
FAQ
When is Bristol Myers Squibb (BMY) presenting at Citi's 2024 Global Healthcare Conference?
Who will represent BMY at Citi's 2024 Global Healthcare Conference?
How can investors watch BMY's presentation at Citi's 2024 Healthcare Conference?
What type of presentation will BMY give at Citi's 2024 Healthcare Conference?
